Identification of an aberrantly spliced form of HDMX in human tumors: A new mechanism for HDM2 stabilization

Simona Giglio, Francesca Mancini, Francesca Gentiletti, Giorgia Sparaco, Lara Felicioni, Fabio Barassi, Carla Martella, Andrea Prodosmo, Stefano Iacovelli, Fiamma Buttitta, Antonella Farsetti, Silvia Soddu, Antonio Marchetti, Ada Sacchi, Alfredo Pontecorvi, Fabiola Moretti

Research output: Contribution to journalArticlepeer-review

Abstract

The HDMX protein is closely related to HDM2 with which it shares different structural domains, particularly the p53 binding domain and the ring finger domain, where the two HDM proteins interact. Several oncogenic forms derived from splicing of HDM2 have been described in cancer. This work aimed at investigating whether analogous forms of HDMX exist in human tumors. Here, we report the characterization of an aberrantly spliced form of HDMX, HDMX211, isolated from the thyroid tumor cell line, ARO. HDMX211 binds and stabilizes the HDM2 protein. Although it lacks the p53 binding domain, HDMX211 also stabilizes p53 by counteracting its degradation by HDM2. However, the resulting p53 is transcriptionally inactive and increasingly associated to its inhibitor HDM2. Expression of HDMX211 strongly enhances the colony-forming ability of human cells in the presence or absence of wild-type p53. Conversely, depletion of HDMX211 by small interfering RNA significantly reduces the growth of ARO cells and increases their sensitivity to chemotherapy. Screening of lung cancer biopsies shows the presence of HDMX211 in samples that overexpress HDM2 protein, supporting a pathologic role for this new protein. This is the first evidence of a variant form of HDMX that has oncogenic potential independently of p53. HDMX211 reveals a new mechanism for overexpression of the oncoprotein HDM2. Most interestingly, it outlines a possible molecular explanation for a yet unclarified tumor phenotype, characterized by simultaneous overexpression of HDM2 and wild-type p53.

Original languageEnglish
Pages (from-to)9687-9694
Number of pages8
JournalCancer Research
Volume65
Issue number21
DOIs
Publication statusPublished - Nov 1 2005

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Identification of an aberrantly spliced form of HDMX in human tumors: A new mechanism for HDM2 stabilization'. Together they form a unique fingerprint.

Cite this